These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 9406704)

  • 1. Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours.
    Eriksson D; Joniani HM; Sheikholvaezin A; Löfroth PO; Johansson L; Riklund Ahlström K; Stigbrand T
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):895-906. PubMed ID: 12721768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies.
    Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
    Cancer; 1997 Dec; 80(12 Suppl):2681-8. PubMed ID: 9406725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental radioimmunotargeting combining nonlabeled, iodine-125-labeled, and anti-idiotypic anticytokeratin monoclonal antibodies: a dosimetric evaluation.
    Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
    Cancer; 1997 Dec; 80(12 Suppl):2689-98. PubMed ID: 9406726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinations of nonlabeled, 125I-labeled, and anti-idiotypic antiplacental alkaline phosphatase monoclonal antibodies at experimental radioimmunotargeting.
    Rossi Norrlund R; Holback D; Johansson L; Hietala SO; Ahlström KR
    Acta Radiol; 1997 Nov; 38(6):1087-93. PubMed ID: 9394676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric comparison of bolus and continuous injections of CC49 monoclonal antibody in a colon cancer xenograft model.
    Roberson PL; Dudek S; Buchsbaum DJ
    Cancer; 1997 Dec; 80(12 Suppl):2567-75. PubMed ID: 9406711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry of fractionated administration of 125I-labeled antibody at experimental radioimmunotargeting.
    Ullén A; Sandström P; Rossi Norrlund R; Rathsman S; Johansson L; Riklund Ahlström K; Hietala SO; Stigbrand T
    Cancer; 1997 Dec; 80(12 Suppl):2510-8. PubMed ID: 9406704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody targeted therapy in cancer: comparison of murine and clinical studies.
    Begent RH; Pedley RB
    Cancer Treat Rev; 1990 Sep; 17(2-3):373-8. PubMed ID: 2272053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models for radiolabeled monoclonal antibodies in cancer research.
    Aas M; Fjeld JG
    Acta Oncol; 1993; 32(7-8):819-24. PubMed ID: 8305231
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.